26
Views
20
CrossRef citations to date
0
Altmetric
Original Article

In Vitro Effects of Sulphasalazine, Azodisal Sodium, and Their Metabolites on Clostridium difficile and Some Other Faecal Bacteria

, , &
Pages 607-612 | Received 29 Jul 1984, Accepted 04 Oct 1984, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

L.-G. Axelsson, T. Midtvedt & A.-C. Bylund-Fellenius. (1996) The Role of Intestinal Bacteria, Bacterial Translocation and Endotoxin in Dextran Sodium Sulphate-Induced Colitis in the Mouse. Microbial Ecology in Health and Disease 9:5, pages 225-237.
Read now
J. Ejderhamn, G. Hedenborg & B. Strandvik. (1992) Long-term double-blind study on the influence of dietary fibres on faecal bile acid excretion in juvenile ulcerative colitis. Scandinavian Journal of Clinical and Laboratory Investigation 52:7, pages 697-706.
Read now

Articles from other publishers (18)

François BlachierFrançois Blachier. 2023. Metabolism of Alimentary Compounds by the Intestinal Microbiota and Health. Metabolism of Alimentary Compounds by the Intestinal Microbiota and Health 27 44 .
Jost Langhorst, Anna K. Koch, Petra Voiss, Gustav J. Dobos & Andreas Rueffer. (2020) Distinct patterns of short-chain fatty acids during flare in patients with ulcerative colitis under treatment with mesalamine or a herbal combination of myrrh, chamomile flowers, and coffee charcoal: secondary analysis of a randomized controlled trial. European Journal of Gastroenterology & Hepatology 32:2, pages 175-180.
Crossref
Maya Olaisen, Olav Spigset, Arnar Flatberg, Atle van Beelen Granlund, Wenche Rødseth Brede, Grethe Albrektsen, Elin Synnøve Røyset, Bodil Gilde, Arne Kristian Sandvik, Tom Christian Martinsen & Reidar Fossmark. (2019) Mucosal 5-aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis. Alimentary Pharmacology & Therapeutics 49:10, pages 1301-1313.
Crossref
Jacinta Walsh, Brendan T Griffin, Gerard Clarke & Niall P Hyland. (2018) Drug-gut microbiota interactions: implications for neuropharmacology. British Journal of Pharmacology 175:24, pages 4415-4429.
Crossref
C. N. Andrews, T. A. Griffiths, J. Kaufman, N. Vergnolle, M. G. Surette & K. P. Rioux. (2011) Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 34:3, pages 374-383.
Crossref
Ilja Tachecí, Marcela Kopáčová, Stanislav Rejchrt & Jan Bureš. (2010) Non-steroidal Anti-inflammatory Drug Induced Injury to the Small Intestine. Acta Medica (Hradec Kralove, Czech Republic) 53:1, pages 3-11.
Crossref
Jaime Kaufman, Tanya A. Griffiths, Michael G. Surette, Susan Ness & Kevin P. Rioux. (2009) Effects of mesalamine (5-aminosalicylic acid) on bacterial gene expression. Inflammatory Bowel Diseases 15:7, pages 985-996.
Crossref
Ronni Wolf, Hagit Matz, Edith Orion, Binnur Tüzün & Yalcin Tüzün. (2002) Miscellaneous treatments, I: sulfasalazine and pentoxifylline: unapproved uses, dosages, or indications. Clinics in Dermatology 20:5, pages 531-546.
Crossref
Claudine Deloménie, Sylvaine Fouix, Sandrine Longuemaux, Naı̈ma BrahimiChantal Bizet, Bertrand Picard, Erick Denamur & Jean-Marie Dupret. (2001) Identification and Functional Characterization of Arylamine N -Acetyltransferases in Eubacteria: Evidence for Highly Selective Acetylation of 5-Aminosalicylic Acid . Journal of Bacteriology 183:11, pages 3417-3427.
Crossref
J.A. Mosquera Martínez. (2001) Fármacos con actividad de fondo en patología inflamatoria articular (II). Medicine - Programa de Formación Médica Continuada Acreditado 8:31, pages 1622-1627.
Crossref
Carty, Macey & Rampton. (2000) Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 14:9, pages 1169-1179.
Crossref
S.P.L. Travis & D.P. Jewell. (1994) Salicylates for ulcerative colitis—their mode of action. Pharmacology & Therapeutics 63:2, pages 135-161.
Crossref
K. Lauritsen, L. S. Laursen, J. Kjeldsen, K. Bukhave & J. Rask-Madsen. (1993) Actions of sulphasalazine and analogues on mucosal eicosanoid formation and metabolism in patients with ulcerative colitis. InflammoPharmacology 2:3, pages 233-245.
Crossref
S. M. GREENFIELD, N. A. PUNCHARD, J. P. TEARE & R. P. H. THOMPSON. (2007) The mode of action of the aminosalicylates in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 7:4, pages 369-383.
Crossref
Donald J. Hermens & Philip B. MinerJr.Jr.. (1991) Exacerbation of ulcerative colitis. Gastroenterology 101:1, pages 254-262.
Crossref
Paula R. Trumbo & Martha A. Raidl. (1991) Effect of sulfasalazine on vitamin B-6 status and metabolism in vitamin B-6adequate and deficient rats. Nutrition Research 11:1, pages 53-60.
Crossref
Malcolm G. Robinson. (1989) New Oral Salicylates in the Therapy of Chronic Idiopathic Inflammatory Bowel Disease. Gastroenterology Clinics of North America 18:1, pages 43-50.
Crossref
D. A. Burke & A. T. Axon. (1987) Clostridium difficile, sulphasalazine, and ulcerative colitis.. Postgraduate Medical Journal 63:745, pages 955-957.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.